Industry Research Reports
Home > Reports > Food & Beverages > Global Medicated Confectionery Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Medicated Confectionery Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Food & Beverages
Published Date: 2025-09-13
Pages: 158 Pages
Report ld: 5046264
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
KEY DRIVERS
Rising prevalence of minor ailments such as sore throat, cough, and digestive discomfort.
Popularity of functional foods and nutraceuticals.
Demand for convenient, easy-to-consume dosage forms compared to traditional syrups or tablets.
Expansion of sugar-free, low-calorie, and natural ingredient-based formulations.
Regional Trends
North America & Europe: High adoption due to OTC regulations, awareness of functional health products, and preference for premium, high-quality formulations.
Asia-Pacific: Fastest market growth driven by increasing healthcare spending, urbanization, and rising middle-class population seeking convenient medicinal solutions.
Emerging markets (Latin America, Middle East & Africa): Growing OTC market and rising awareness of self-care products fuel moderate growth.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Medicated Confectionery market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Medicated Confectionery Market Size(US$)
CAGR 2025-2031
5.2%
Market Size,2031
USD 9,372
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 6,914 million
Market Forecast in 2031(Value)
US$ 9,372 million
CAGR
5.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Medicated Confectionery market is projected to grow from US$ 6520 million in 2024 to US$ 9372 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Medicated Confectionery refers to confectionery products formulated with active medicinal ingredients or functional compounds, intended to provide relief from minor ailments such as sore throat, cough, mouth dryness, indigestion, or to deliver vitamins and herbal extracts. Unlike regular candies, medicated confectionery combines the taste and texture of sweets with therapeutic or functional benefits, and is often classified as an OTC (over-the-counter) healthcare product. Common forms include lozenges, hard candies, chewing gums, and gummies with added active substances.
MARKET SEGMENTATION
By Company
- Perfetti Van Melle (Halls)
- Reckitt Benckiser (Strepsils)
- Ricola AG
- Jakemans
- Wrigley Company
- Mondelez International (Ernest Jackson)
- Nestle
- Procter & Gamble
- Meda Pharmaceuticals
- UHA Mikakuto
- Herbion International
- HEXOS
- Lofthouse of Fleetwood
- Läkerol
- Luden's
- Olbas
- Baker Perkins Limited
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Lozenges
- Chewable Tablets
- Gummy
- Other
Segment by Application
- Pharmacies/Drugstores
- Supermarkets/Convenience Stores
- Health & Wellness Stores
- Hospital/Clinic Pharmacies
- Online Retailers
CHAPTER OUTLINE
Chapter 1: Defines the Medicated Confectionery study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Medicated Confectionery: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medicated Confectionery Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Lozenges
1.2.3 Chewable Tablets
1.2.4 Gummy
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Medicated Confectionery Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmacies/Drugstores
1.3.3 Supermarkets/Convenience Stores
1.3.4 Health & Wellness Stores
1.3.5 Hospital/Clinic Pharmacies
1.3.6 Online Retailers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medicated Confectionery Revenue Estimates and Forecasts 2020-2031
2.2 Global Medicated Confectionery Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Medicated Confectionery Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Medicated Confectionery Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Lozenges Market Size by Players
3.3.2 Chewable Tablets Market Size by Players
3.3.3 Gummy Market Size by Players
3.3.4 Other Market Size by Players
3.4 Global Medicated Confectionery Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Medicated Confectionery Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Medicated Confectionery Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Medicated Confectionery Market Size by Type (2020-2031)
6.4 North America Medicated Confectionery Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Medicated Confectionery Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Medicated Confectionery Market Size by Type (2020-2031)
7.4 Europe Medicated Confectionery Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Medicated Confectionery Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Medicated Confectionery Market Size by Type (2020-2031)
8.4 Asia-Pacific Medicated Confectionery Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Medicated Confectionery Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Medicated Confectionery Market Size by Type (2020-2031)
9.4 Central and South America Medicated Confectionery Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Medicated Confectionery Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Medicated Confectionery Market Size by Type (2020-2031)
10.4 Middle East and Africa Medicated Confectionery Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Medicated Confectionery Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Perfetti Van Melle (Halls)
11.1.1 Perfetti Van Melle (Halls) Corporation Information
11.1.2 Perfetti Van Melle (Halls) Business Overview
11.1.3 Perfetti Van Melle (Halls) Medicated Confectionery Product Features and Attributes
11.1.4 Perfetti Van Melle (Halls) Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.1.5 Perfetti Van Melle (Halls) Medicated Confectionery Revenue by Product in 2024
11.1.6 Perfetti Van Melle (Halls) Medicated Confectionery Revenue by Application in 2024
11.1.7 Perfetti Van Melle (Halls) Medicated Confectionery Revenue by Geographic Area in 2024
11.1.8 Perfetti Van Melle (Halls) Medicated Confectionery SWOT Analysis
11.1.9 Perfetti Van Melle (Halls) Recent Developments
11.2 Reckitt Benckiser (Strepsils)
11.2.1 Reckitt Benckiser (Strepsils) Corporation Information
11.2.2 Reckitt Benckiser (Strepsils) Business Overview
11.2.3 Reckitt Benckiser (Strepsils) Medicated Confectionery Product Features and Attributes
11.2.4 Reckitt Benckiser (Strepsils) Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.2.5 Reckitt Benckiser (Strepsils) Medicated Confectionery Revenue by Product in 2024
11.2.6 Reckitt Benckiser (Strepsils) Medicated Confectionery Revenue by Application in 2024
11.2.7 Reckitt Benckiser (Strepsils) Medicated Confectionery Revenue by Geographic Area in 2024
11.2.8 Reckitt Benckiser (Strepsils) Medicated Confectionery SWOT Analysis
11.2.9 Reckitt Benckiser (Strepsils) Recent Developments
11.3 Ricola AG
11.3.1 Ricola AG Corporation Information
11.3.2 Ricola AG Business Overview
11.3.3 Ricola AG Medicated Confectionery Product Features and Attributes
11.3.4 Ricola AG Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.3.5 Ricola AG Medicated Confectionery Revenue by Product in 2024
11.3.6 Ricola AG Medicated Confectionery Revenue by Application in 2024
11.3.7 Ricola AG Medicated Confectionery Revenue by Geographic Area in 2024
11.3.8 Ricola AG Medicated Confectionery SWOT Analysis
11.3.9 Ricola AG Recent Developments
11.4 Jakemans
11.4.1 Jakemans Corporation Information
11.4.2 Jakemans Business Overview
11.4.3 Jakemans Medicated Confectionery Product Features and Attributes
11.4.4 Jakemans Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.4.5 Jakemans Medicated Confectionery Revenue by Product in 2024
11.4.6 Jakemans Medicated Confectionery Revenue by Application in 2024
11.4.7 Jakemans Medicated Confectionery Revenue by Geographic Area in 2024
11.4.8 Jakemans Medicated Confectionery SWOT Analysis
11.4.9 Jakemans Recent Developments
11.5 Wrigley Company
11.5.1 Wrigley Company Corporation Information
11.5.2 Wrigley Company Business Overview
11.5.3 Wrigley Company Medicated Confectionery Product Features and Attributes
11.5.4 Wrigley Company Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.5.5 Wrigley Company Medicated Confectionery Revenue by Product in 2024
11.5.6 Wrigley Company Medicated Confectionery Revenue by Application in 2024
11.5.7 Wrigley Company Medicated Confectionery Revenue by Geographic Area in 2024
11.5.8 Wrigley Company Medicated Confectionery SWOT Analysis
11.5.9 Wrigley Company Recent Developments
11.6 Mondelez International (Ernest Jackson)
11.6.1 Mondelez International (Ernest Jackson) Corporation Information
11.6.2 Mondelez International (Ernest Jackson) Business Overview
11.6.3 Mondelez International (Ernest Jackson) Medicated Confectionery Product Features and Attributes
11.6.4 Mondelez International (Ernest Jackson) Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.6.5 Mondelez International (Ernest Jackson) Recent Developments
11.7 Nestle
11.7.1 Nestle Corporation Information
11.7.2 Nestle Business Overview
11.7.3 Nestle Medicated Confectionery Product Features and Attributes
11.7.4 Nestle Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.7.5 Nestle Recent Developments
11.8 Procter & Gamble
11.8.1 Procter & Gamble Corporation Information
11.8.2 Procter & Gamble Business Overview
11.8.3 Procter & Gamble Medicated Confectionery Product Features and Attributes
11.8.4 Procter & Gamble Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.8.5 Procter & Gamble Recent Developments
11.9 Meda Pharmaceuticals
11.9.1 Meda Pharmaceuticals Corporation Information
11.9.2 Meda Pharmaceuticals Business Overview
11.9.3 Meda Pharmaceuticals Medicated Confectionery Product Features and Attributes
11.9.4 Meda Pharmaceuticals Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.9.5 Meda Pharmaceuticals Recent Developments
11.10 UHA Mikakuto
11.10.1 UHA Mikakuto Corporation Information
11.10.2 UHA Mikakuto Business Overview
11.10.3 UHA Mikakuto Medicated Confectionery Product Features and Attributes
11.10.4 UHA Mikakuto Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Herbion International
11.11.1 Herbion International Corporation Information
11.11.2 Herbion International Business Overview
11.11.3 Herbion International Medicated Confectionery Product Features and Attributes
11.11.4 Herbion International Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.11.5 Herbion International Recent Developments
11.12 HEXOS
11.12.1 HEXOS Corporation Information
11.12.2 HEXOS Business Overview
11.12.3 HEXOS Medicated Confectionery Product Features and Attributes
11.12.4 HEXOS Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.12.5 HEXOS Recent Developments
11.13 Lofthouse of Fleetwood
11.13.1 Lofthouse of Fleetwood Corporation Information
11.13.2 Lofthouse of Fleetwood Business Overview
11.13.3 Lofthouse of Fleetwood Medicated Confectionery Product Features and Attributes
11.13.4 Lofthouse of Fleetwood Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.13.5 Lofthouse of Fleetwood Recent Developments
11.14 Läkerol
11.14.1 Läkerol Corporation Information
11.14.2 Läkerol Business Overview
11.14.3 Läkerol Medicated Confectionery Product Features and Attributes
11.14.4 Läkerol Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.14.5 Läkerol Recent Developments
11.15 Luden's
11.15.1 Luden's Corporation Information
11.15.2 Luden's Business Overview
11.15.3 Luden's Medicated Confectionery Product Features and Attributes
11.15.4 Luden's Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.15.5 Luden's Recent Developments
11.16 Olbas
11.16.1 Olbas Corporation Information
11.16.2 Olbas Business Overview
11.16.3 Olbas Medicated Confectionery Product Features and Attributes
11.16.4 Olbas Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.16.5 Olbas Recent Developments
11.17 Baker Perkins Limited
11.17.1 Baker Perkins Limited Corporation Information
11.17.2 Baker Perkins Limited Business Overview
11.17.3 Baker Perkins Limited Medicated Confectionery Product Features and Attributes
11.17.4 Baker Perkins Limited Medicated Confectionery Revenue and Gross Margin (2020-2025)
11.17.5 Baker Perkins Limited Recent Developments
12 Medicated ConfectioneryIndustry Chain Analysis
12.1 Medicated Confectionery Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Medicated Confectionery Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Medicated Confectionery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Medicated Confectionery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Medicated Confectionery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Medicated Confectionery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Medicated Confectionery Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Medicated Confectionery Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Medicated Confectionery Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Medicated Confectionery Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Medicated Confectionery by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicated Confectionery as of 2024)
Table 11. Global Medicated Confectionery Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Medicated Confectionery Companies Headquarters
Table 13. Global Medicated Confectionery Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Medicated Confectionery Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Medicated Confectionery Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Medicated Confectionery Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Medicated Confectionery Revenue by Application (2026-2031) & (US$ Million)
Table 21. Medicated Confectionery High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Medicated Confectionery Growth Accelerators and Market Barriers
Table 25. North America Medicated Confectionery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Medicated Confectionery Growth Accelerators and Market Barriers
Table 27. Europe Medicated Confectionery Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Medicated Confectionery Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Medicated Confectionery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Medicated Confectionery Investment Opportunities and Key Challenges
Table 31. Central and South America Medicated Confectionery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Medicated Confectionery Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Medicated Confectionery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Perfetti Van Melle (Halls) Corporation Information
Table 35. Perfetti Van Melle (Halls) Description and Major Businesses
Table 36. Perfetti Van Melle (Halls) Product Features and Attributes
Table 37. Perfetti Van Melle (Halls) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Perfetti Van Melle (Halls) Revenue Proportion by Product in 2024
Table 39. Perfetti Van Melle (Halls) Revenue Proportion by Application in 2024
Table 40. Perfetti Van Melle (Halls) Revenue Proportion by Geographic Area in 2024
Table 41. Perfetti Van Melle (Halls) Medicated Confectionery SWOT Analysis
Table 42. Perfetti Van Melle (Halls) Recent Developments
Table 43. Reckitt Benckiser (Strepsils) Corporation Information
Table 44. Reckitt Benckiser (Strepsils) Description and Major Businesses
Table 45. Reckitt Benckiser (Strepsils) Product Features and Attributes
Table 46. Reckitt Benckiser (Strepsils) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Reckitt Benckiser (Strepsils) Revenue Proportion by Product in 2024
Table 48. Reckitt Benckiser (Strepsils) Revenue Proportion by Application in 2024
Table 49. Reckitt Benckiser (Strepsils) Revenue Proportion by Geographic Area in 2024
Table 50. Reckitt Benckiser (Strepsils) Medicated Confectionery SWOT Analysis
Table 51. Reckitt Benckiser (Strepsils) Recent Developments
Table 52. Ricola AG Corporation Information
Table 53. Ricola AG Description and Major Businesses
Table 54. Ricola AG Product Features and Attributes
Table 55. Ricola AG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Ricola AG Revenue Proportion by Product in 2024
Table 57. Ricola AG Revenue Proportion by Application in 2024
Table 58. Ricola AG Revenue Proportion by Geographic Area in 2024
Table 59. Ricola AG Medicated Confectionery SWOT Analysis
Table 60. Ricola AG Recent Developments
Table 61. Jakemans Corporation Information
Table 62. Jakemans Description and Major Businesses
Table 63. Jakemans Product Features and Attributes
Table 64. Jakemans Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Jakemans Revenue Proportion by Product in 2024
Table 66. Jakemans Revenue Proportion by Application in 2024
Table 67. Jakemans Revenue Proportion by Geographic Area in 2024
Table 68. Jakemans Medicated Confectionery SWOT Analysis
Table 69. Jakemans Recent Developments
Table 70. Wrigley Company Corporation Information
Table 71. Wrigley Company Description and Major Businesses
Table 72. Wrigley Company Product Features and Attributes
Table 73. Wrigley Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Wrigley Company Revenue Proportion by Product in 2024
Table 75. Wrigley Company Revenue Proportion by Application in 2024
Table 76. Wrigley Company Revenue Proportion by Geographic Area in 2024
Table 77. Wrigley Company Medicated Confectionery SWOT Analysis
Table 78. Wrigley Company Recent Developments
Table 79. Mondelez International (Ernest Jackson) Corporation Information
Table 80. Mondelez International (Ernest Jackson) Description and Major Businesses
Table 81. Mondelez International (Ernest Jackson) Product Features and Attributes
Table 82. Mondelez International (Ernest Jackson) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Mondelez International (Ernest Jackson) Recent Developments
Table 84. Nestle Corporation Information
Table 85. Nestle Description and Major Businesses
Table 86. Nestle Product Features and Attributes
Table 87. Nestle Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Nestle Recent Developments
Table 89. Procter & Gamble Corporation Information
Table 90. Procter & Gamble Description and Major Businesses
Table 91. Procter & Gamble Product Features and Attributes
Table 92. Procter & Gamble Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Procter & Gamble Recent Developments
Table 94. Meda Pharmaceuticals Corporation Information
Table 95. Meda Pharmaceuticals Description and Major Businesses
Table 96. Meda Pharmaceuticals Product Features and Attributes
Table 97. Meda Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Meda Pharmaceuticals Recent Developments
Table 99. UHA Mikakuto Corporation Information
Table 100. UHA Mikakuto Description and Major Businesses
Table 101. UHA Mikakuto Product Features and Attributes
Table 102. UHA Mikakuto Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. UHA Mikakuto Recent Developments
Table 104. Herbion International Corporation Information
Table 105. Herbion International Description and Major Businesses
Table 106. Herbion International Product Features and Attributes
Table 107. Herbion International Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Herbion International Recent Developments
Table 109. HEXOS Corporation Information
Table 110. HEXOS Description and Major Businesses
Table 111. HEXOS Product Features and Attributes
Table 112. HEXOS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. HEXOS Recent Developments
Table 114. Lofthouse of Fleetwood Corporation Information
Table 115. Lofthouse of Fleetwood Description and Major Businesses
Table 116. Lofthouse of Fleetwood Product Features and Attributes
Table 117. Lofthouse of Fleetwood Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Lofthouse of Fleetwood Recent Developments
Table 119. Läkerol Corporation Information
Table 120. Läkerol Description and Major Businesses
Table 121. Läkerol Product Features and Attributes
Table 122. Läkerol Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Läkerol Recent Developments
Table 124. Luden's Corporation Information
Table 125. Luden's Description and Major Businesses
Table 126. Luden's Product Features and Attributes
Table 127. Luden's Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Luden's Recent Developments
Table 129. Olbas Corporation Information
Table 130. Olbas Description and Major Businesses
Table 131. Olbas Product Features and Attributes
Table 132. Olbas Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Olbas Recent Developments
Table 134. Baker Perkins Limited Corporation Information
Table 135. Baker Perkins Limited Description and Major Businesses
Table 136. Baker Perkins Limited Product Features and Attributes
Table 137. Baker Perkins Limited Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Baker Perkins Limited Recent Developments
Table 139. Raw Materials Key Suppliers
Table 140. Distributors List
Table 141. Market Trends and Market Evolution
Table 142. Market Drivers and Opportunities
Table 143. Market Challenges, Risks, and Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Medicated Confectionery Product Picture
Figure 2. Global Medicated Confectionery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Lozenges Product Picture
Figure 4. Chewable Tablets Product Picture
Figure 5. Gummy Product Picture
Figure 6. Other Product Picture
Figure 7. Global Medicated Confectionery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Pharmacies/Drugstores
Figure 9. Supermarkets/Convenience Stores
Figure 10. Health & Wellness Stores
Figure 11. Hospital/Clinic Pharmacies
Figure 12. Online Retailers
Figure 13. Medicated Confectionery Report Years Considered
Figure 14. Global Medicated Confectionery Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 16. Global Medicated Confectionery Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Medicated Confectionery Revenue Market Share by Region (2020-2031)
Figure 18. Global Medicated Confectionery Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Lozenges Revenue Market Share by Player in 2024
Figure 21. Chewable Tablets Revenue Market Share by Player in 2024
Figure 22. Gummy Revenue Market Share by Player in 2024
Figure 23. Other Revenue Market Share by Player in 2024
Figure 24. Global Medicated Confectionery Revenue Market Share by Type (2020-2031)
Figure 25. Global Medicated Confectionery Revenue Market Share by Application (2020-2031)
Figure 26. North America Medicated Confectionery Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Players Medicated Confectionery Revenue (US$ Million) in 2024
Figure 28. North America Medicated Confectionery Revenue (US$ Million) by Type (2020 - 2031)
Figure 29. North America Medicated Confectionery Revenue (US$ Million) by Application (2020-2031)
Figure 30. US Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 31. Canada Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 32. Mexico Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 33. Europe Medicated Confectionery Revenue YoY (2020-2031) & (US$ Million)
Figure 34. Europe Top 5 Players Medicated Confectionery Revenue (US$ Million) in 2024
Figure 35. Europe Medicated Confectionery Revenue (US$ Million) by Type (2020-2031)
Figure 36. Europe Medicated Confectionery Revenue (US$ Million) by Application (2020-2031)
Figure 37. Germany Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 38. France Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 39. U.K. Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 40. Italy Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 41. Russia Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Medicated Confectionery Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Top 8 Players Medicated Confectionery Revenue (US$ Million) in 2024
Figure 44. Asia-Pacific Medicated Confectionery Revenue (US$ Million) by Type (2020-2031)
Figure 45. Asia-Pacific Medicated Confectionery Revenue (US$ Million) by Application (2020-2031)
Figure 46. Indonesia Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 47. Japan Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 48. South Korea Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 49. Australia Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 50. India Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 51. Indonesia Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 52. Vietnam Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 53. Malaysia Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 54. Philippines Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 55. Singapore Medicated Confectionery Revenue (2020-2031) & (US$ Million)
Figure 56. Central and South America Medicated Confectionery Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Central and South America Top 5 Players Medicated Confectionery Revenue (US$ Million) in 2024
Figure 58. Central and South America Medicated Confectionery Revenue (US$ Million) by Type (2020-2031)
Figure 59. Central and South America Medicated Confectionery Revenue (US$ Million) by Application (2020-2031)
Figure 60. Brazil Medicated Confectionery Revenue (2020-2025) & (US$ Million)
Figure 61. Argentina Medicated Confectionery Revenue (2020-2025) & (US$ Million)
Figure 62. Middle East and Africa Medicated Confectionery Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Middle East and Africa Top 5 Players Medicated Confectionery Revenue (US$ Million) in 2024
Figure 64. South America Medicated Confectionery Revenue (US$ Million) by Type (2020-2031)
Figure 65. Middle East and Africa Medicated Confectionery Revenue (US$ Million) by Application (2020-2031)
Figure 66. GCC Countries Medicated Confectionery Revenue (2020-2025) & (US$ Million)
Figure 67. Israel Medicated Confectionery Revenue (2020-2025) & (US$ Million)
Figure 68. Egypt Medicated Confectionery Revenue (2020-2025) & (US$ Million)
Figure 69. South Africa Medicated Confectionery Revenue (2020-2025) & (US$ Million)
Figure 70. Medicated Confectionery Industry Chain Mapping
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Medicated Confectionery in 2025?
The global market size of Medicated Confectionery in 2025 was 6914 Million USD.
What was the global market size of Medicated Confectionery in 2031?
What is the annual compound growth rate of the global Medicated Confectionery market size from 2025 to 2031?
Which companies rank high in the global Medicated Confectionery market?
Which region is expected to have the highest market share?
Related Reports
Global Medicated Confectionery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Medicated Confectionery market size was US$ 6914 million in 2025 and is forecast to reach a readjusted size of US$ 9810 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 104
USD 4250.00
(Single User License)
Global Medicated Confectionery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Medicated Confectionery market is projected to grow from US$ 6914 million in 2025 to US$ 9810 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-09
Pages: 158
USD 4900.00
(Single User License)
Medicated Confectionery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medicated Confectionery was estimated to be worth US$ 6914 million in 2025 and is projected to reach US$ 9810 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 126
USD 3950.00
(Single User License)
Global Medicated Confectionery Market Research Report 2026
The global Medicated Confectionery market was valued at US$ 6914 million in 2025 and is anticipated to reach US$ 9810 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 138
USD 2900.00
(Single User License)
Medicated Confectionery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Medicated Confectionery was estimated to be worth US$ 6520 million in 2024 and is forecast to a readjusted size of US$ 9372 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-09-13
Pages: 134
USD 3950.00
(Single User License)
Global Medicated Confectionery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Medicated Confectionery market size was US$ 6520 million in 2024 and is forecast to a readjusted size of US$ 9372 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-09-13
Pages: 105
USD 4250.00
(Single User License)
Global Medicated Confectionery Market Research Report 2025
The global market for Medicated Confectionery was valued at US$ 6520 million in the year 2024 and is projected to reach a revised size of US$ 9372 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-09-13
Pages: 96
USD 2900.00
(Single User License)
Medicated Confectionery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Medicated Confectionery was estimated to be worth US$ 8852 million in 2024 and is forecast to a readjusted size of US$ 10590 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 132
USD 3950.00
(Single User License)
Global Medicated Confectionery Market Insights, Forecast to 2030
The global Medicated Confectionery market is projected to grow from US$ 8647.2 million in 2024 to US$ 10100 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.6% during the forecast period.
Published Date: 2024-04-15
Pages: 119
USD 4900.00
(Single User License)
Medicated Confectionery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Medicated Confectionery was estimated to be worth US$ 8398.5 million in 2023 and is forecast to a readjusted size of US$ 10100 million by 2030 with a CAGR of 2.6% during the forecast period 2024-2030
Published Date: 2024-01-16
Pages: 144
USD 3950.00
(Single User License)
Global Medicated Confectionery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Medicated Confectionery market size was US$ 6914 million in 2025 and is forecast to reach a readjusted size of US$ 9810 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 104
USD 4250.00 (Single User License)Global Medicated Confectionery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Medicated Confectionery market is projected to grow from US$ 6914 million in 2025 to US$ 9810 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-09
Pages: 158
USD 4900.00 (Single User License)Medicated Confectionery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medicated Confectionery was estimated to be worth US$ 6914 million in 2025 and is projected to reach US$ 9810 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-03-05
Pages: 126
USD 3950.00 (Single User License)Global Medicated Confectionery Market Research Report 2026
The global Medicated Confectionery market was valued at US$ 6914 million in 2025 and is anticipated to reach US$ 9810 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-03-05
Pages: 138
USD 2900.00 (Single User License)Medicated Confectionery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Medicated Confectionery was estimated to be worth US$ 6520 million in 2024 and is forecast to a readjusted size of US$ 9372 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-09-13
Pages: 134
USD 3950.00 (Single User License)Global Medicated Confectionery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Medicated Confectionery market size was US$ 6520 million in 2024 and is forecast to a readjusted size of US$ 9372 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-09-13
Pages: 105
USD 4250.00 (Single User License)Global Medicated Confectionery Market Research Report 2025
The global market for Medicated Confectionery was valued at US$ 6520 million in the year 2024 and is projected to reach a revised size of US$ 9372 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-09-13
Pages: 96
USD 2900.00 (Single User License)Medicated Confectionery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Medicated Confectionery was estimated to be worth US$ 8852 million in 2024 and is forecast to a readjusted size of US$ 10590 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 132
USD 3950.00 (Single User License)Global Medicated Confectionery Market Insights, Forecast to 2030
The global Medicated Confectionery market is projected to grow from US$ 8647.2 million in 2024 to US$ 10100 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.6% during the forecast period.
Published: 2024-04-15
Pages: 119
USD 4900.00 (Single User License)Medicated Confectionery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Medicated Confectionery was estimated to be worth US$ 8398.5 million in 2023 and is forecast to a readjusted size of US$ 10100 million by 2030 with a CAGR of 2.6% during the forecast period 2024-2030
Published: 2024-01-16
Pages: 144
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
KEY DRIVERS
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now